AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 177 filers reported holding AXSOME THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $373,982 | -5.8% | 5,351 | -3.2% | 0.00% | – |
Q2 2023 | $397,170 | +19.4% | 5,527 | +2.5% | 0.00% | – |
Q1 2023 | $332,578 | -21.5% | 5,392 | -1.9% | 0.00% | – |
Q4 2022 | $423,829 | +69.5% | 5,495 | -1.9% | 0.00% | – |
Q3 2022 | $250,000 | -69.3% | 5,600 | -73.7% | 0.00% | -100.0% |
Q2 2022 | $815,000 | -7.3% | 21,287 | +0.2% | 0.00% | 0.0% |
Q1 2022 | $879,000 | +9.6% | 21,252 | -0.0% | 0.00% | 0.0% |
Q4 2021 | $802,000 | +14.1% | 21,253 | -0.2% | 0.00% | 0.0% |
Q3 2021 | $703,000 | -51.0% | 21,295 | +0.2% | 0.00% | 0.0% |
Q2 2021 | $1,435,000 | +19.5% | 21,260 | +0.2% | 0.00% | 0.0% |
Q1 2021 | $1,201,000 | -28.9% | 21,228 | +2.4% | 0.00% | -50.0% |
Q4 2020 | $1,689,000 | +14.3% | 20,733 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $1,478,000 | -13.3% | 20,733 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $1,705,000 | +2839.7% | 20,733 | +1973.3% | 0.00% | – |
Q1 2020 | $58,000 | -44.2% | 1,000 | 0.0% | 0.00% | – |
Q4 2019 | $104,000 | – | 1,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 758,794 | $53,032,113 | 65.14% |
Fairmount Funds Management LLC | 2,341,238 | $163,629,124 | 19.69% |
Ally Bridge Group (NY) LLC | 110,600 | $7,729,834 | 9.07% |
RTW INVESTMENTS, LP | 4,489,596 | $313,777,864 | 6.62% |
SVB FINANCIAL GROUP | 33,849 | $2,365,707 | 4.45% |
BVF INC/IL | 2,131,100 | $148,942,579 | 4.02% |
Altium Capital Management LP | 92,000 | $6,429,880 | 3.35% |
Tri Locum Partners LP | 142,510 | $9,960,024 | 3.18% |
TANG CAPITAL MANAGEMENT LLC | 320,000 | $22,364,800 | 3.16% |
Deep Track Capital, LP | 1,140,745 | $79,726,668 | 3.08% |